Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1

Cited by (827)

Items 101–200 of 827

1. Identification of constitutional MLH1 epimutations and promoter variants in colorectal cancer patients from the Colon Cancer Family Registry
   Robyn Lynne Ward, Timothy Dobbins, Noralane M. Lindor, Robert W. Rapkins, Megan Philippa Hitchins · 2012 · Genetics in Medicine
2. Protein tyrosine phosphatase variants in human hereditary disorders and disease susceptibilities
   Wiljan J A J Hendriks, Rafael Pulido · 2013 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
3. Familial Colon Cancer Syndromes: an Update of a Rapidly Evolving Field
   Swati G. Patel, Dennis J. Ahnen · 2012 · Current Gastroenterology Reports
4. Carcinogenic mechanisms of endometrial cancer: Involvement of genetics and epigenetics
   Kouji Banno, Megumi Yanokura, Miho Iida, Kenta Masuda, Daisuke Aoki · 2014 · Journal of obstetrics and gynaecology research
5. Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation
   Tristan Snowsill, Helen F. Coelho, Nicola Huxley, Tracey Jones-Hughes, Simon Briscoe, Ian M. Frayling, Chris Hyde · 2017 · Health Technology Assessment
6. Heritable DNA methylation marks associated with susceptibility to breast cancer
   Jihoon Eric Joo, James G. Dowty, Roger Laughlin Milne, Ee Ming Wong, Pierre‐Antoine Dugué, Dallas R. English, John Llewelyn Hopper, David E. Goldgar, Graham G. Giles, Melissa C. Southey et al. · 2018 · Nature Communications
7. Lynch syndrome-associated neoplasms: a discussion on histopathology and immunohistochemistry
   Jinru Shia, Susanne Holck, Giovanni De Petris, Joel K. Greenson, David S. Klimstra · 2013 · Familial Cancer
8. The role of aberrant DNA methylation in cancer initiation and clinical impacts
   Franziska Geissler, Ksenija Nesic, Olga Kondrashova, Alexander Dobrovic, Elizabeth M. Swisher, Clare L. Scott, Matthew J. Wakefield · 2024 · Therapeutic Advances in Medical Oncology
9. Molecular and prognostic heterogeneity of microsatellite-unstable colorectal cancer
   Jung Ho Kim · 2014 · World Journal of Gastroenterology
10. Identification of rare de novo epigenetic variations in congenital disorders
    Mafalda Barbosa, Ricky S. Joshi, Paras Garg, Alejandro Martin-Trujillo, Nihir Patel, Bharati Jadhav, Corey T. Watson, William T. Gibson, Kelsey Chetnik, Chloé Tessereau et al. · 2018 · Nature Communications
11. Frequency of Deletions of EPCAM (TACSTD1) in MSH2-Associated Lynch Syndrome Cases
    Kandelaria M. Rumilla, Karen V. Schowalter, Noralane M. Lindor, Brittany C. Thomas, Kara A. Mensink, Steve Gallinger, Spring Holter, Polly A. Newcomb, John D. Potter, Mark A. Jenkins et al. · 2011 · Journal of Molecular Diagnostics
12. The Alu-Rich Genomic Architecture of SPAST Predisposes to Diverse and Functionally Distinct Disease-Associated CNV Alleles
    Philip M. Boone, Bo Yuan, Ian M. Campbell, Jennifer C. Scull, Marjorie A. Withers, Brett Baggett, Christine R. Beck, Christine J. Shaw, Paweł Stankiewicz, Paolo M. Moretti et al. · 2014 · The American Journal of Human Genetics
13. Clinical problems of colorectal cancer and endometrial cancer cases with unknown cause of tumor mismatch repair deficiency (suspected Lynch syndrome)
    Aung Ko Win, Daniel D. Buchanan, Christophe Rosty, Mark Clendenning, Amanda B. Spurdle · 2014 · The Application of Clinical Genetics
14. Risk-Reducing Bilateral Salpingo-Oophorectomy for Ovarian Cancer: A Review and Clinical Guide for Hereditary Predisposition Genes
    Ying L. Liu, Kelsey E. Breen, Amanda Catchings, Megha Ranganathan, Alicia J. Latham, Deborah J. Goldfrank, Rachel N. Grisham, Kara Long Roche, Melissa K. Frey, Dennis S. Chi et al. · 2021 · JCO Oncology Practice
15. A Dominantly Inherited 5′ UTR Variant Causing Methylation-Associated Silencing of BRCA1 as a Cause of Breast and Ovarian Cancer
    Evans, D.Gareth R., van Veen, Elke M., Byers, Helen J., Wallace, Andrew J., Ellingford, Jamie M., Beaman, Glenda, Santoyo-Lopez, Javier, Aitman, Timothy J., Eccles, Diana M., Lalloo, Fiona I. et al. · 2018 · The American Journal of Human Genetics
16. Genetic and genomic basis of the mismatch repair system involved in Lynch syndrome
    Kazuo Tamura, Motohide Kaneda, Mashu Futagawa, Miho Takeshita, Sanghyuk Kim, Mina Nakama, Norihito Kawashita, Junko Tatsumi‐Miyajima · 2019 · International Journal of Clinical Oncology
17. Biallelic MLH1 SNP cDNA expression or constitutional promoter methylation can hide genomic rearrangements causing Lynch syndrome
    Monika Morak, Udo Koehler, Hans K. Schackert, Verena Steinke, Brigitte Royer‐Pokora, Karsten Schulmann, Matthias Kloor, W. Höchter, Josef Weingart, C. Keiling et al. · 2011 · Journal of Medical Genetics
18. A PRDX1 mutant allele causes a MMACHC secondary epimutation in cblC patients
    Guéant, Jean-Louis, Chéry, Céline, Oussalah, Abderrahim, Nadaf, Javad, Coelho, David, Josse, Thomas, Flayac, Justine, Robert, Aurélie, Koscinski, Isabelle, Gastin, Isabelle et al. · 2018 · Nature Communications
19. De novo constitutional MLH1 epimutations confer early‐onset colorectal cancer in two new sporadic Lynch syndrome cases, with derivation of the epimutation on the paternal allele in one
    Ajay Goel, Thuy‐Phuong Nguyen, Hon‐Chiu Eastwood Leung, Takeshi Nagasaka, Jennifer Rhees, Erin C. Hotchkiss, Mildred Arnold, Pia Banerji, Minoru Koi, Chau‐To Kwok et al. · 2010 · International Journal of Cancer
20. MSI/MMR-deficient tumor diagnosis: Which standard for screening and for diagnosis? Diagnostic modalities for the colon and other sites: Differences between tumors
    Svrcek, Magali, Lascols, Olivier, Cohen, Romain, Collura, Ada, Jonchère, Vincent, Fléjou, Jean-François, Buhard, Olivier, Duval, Alex · 2019 · Bulletin du Cancer
21. The promise of PD-1 inhibitors in gastro-esophageal cancers: microsatellite instability vs. PD-L1
    Zhaohui Jin, Harry H. Yoon · 2016 · Journal of Gastrointestinal Oncology
22. Diagnosis of Lynch Syndrome and Strategies to Distinguish Lynch-Related Tumors from Sporadic MSI/dMMR Tumors
    Julie Leclerc, Catherine Vermaut, Marie‐Pierre Buisine · 2021 · Cancers
23. Allele-specific CDH1 downregulation and hereditary diffuse gastric cancer
    Hugo Celso Pinheiro, Renata Bordeira–Carriço, Susana Seixas, Joana Carvalho, Janine Senz, Patrícia Oliveira, Penha Inácio, Leonor Gusmão, Jorge Rocha, David D. Huntsman et al. · 2009 · Human Molecular Genetics
24. Immunotherapy and patients treated for cancer with microsatellite instability
    Raphaël Colle, Romain Cohen, D. Cochereau, Alex Duval, Olivier Lascols, Daniel López‐Trabada, Pauline Afchain, Isabelle Trouilloud, Yann R. Parc, Jérémie H. Lefèvre et al. · 2016 · Bulletin du Cancer
25. Opportunities for immunotherapy in microsatellite instable colorectal cancer
    Harm Westdorp, Felix L. Fennemann, Robbert D.A. Weren, Tanya M. Bisseling, Marjolijn J. L. Ligtenberg, Carl Gustav Figdor, Gerty Schreibelt, Nicoline Hoogerbrugge, Florian Wimmers, I. Jolanda M. de Vries · 2016 · Cancer Immunology Immunotherapy
26. EPCAM mutation update: Variants associated with congenital tufting enteropathy and Lynch syndrome
    Sagar J. Pathak, James L. Mueller, Kevin Okamoto, Barun Das, Jozef Hertecant, Lynn Greenhalgh, Trevor R. P. Cole, Vered Pinsk, Baruch Yerushalmi, Ödül Eğritaş Gürkan et al. · 2018 · Human Mutation
27. The role of epigenetics in Lynch syndrome
    Megan Philippa Hitchins · 2013 · Familial Cancer
28. Era of universal testing of microsatellite instability in colorectal cancer
    Xuchen Zhang, Jia Li · 2013 · World Journal of Gastrointestinal Oncology
29. History, Genetics, and Strategies for Cancer Prevention in Lynch Syndrome
    Fay Kastrinos, Elena M. Stoffel · 2013 · Clinical Gastroenterology and Hepatology
30. Histology-agnostic drug development — considering issues beyond the tissue
    Roberto Carmagnani Pestana, Shiraj Sen, Brian Paul Hobbs, David S. Hong · 2020 · Nature Reviews Clinical Oncology
31. Human metastable epiallele candidates link to common disorders
    Ronald Alan Harris, Dorottya Nagy‐Szakal, Richárd Kellermayer · 2013 · Epigenetics
32. Cis-ruption mechanisms: disruption of cis-regulatory control as a cause of human genetic disease
    Dirk‐Jan Kleinjan, P. Coutinho · 2009 · Briefings in Functional Genomics and Proteomics
33. Mutations and epimutations in the origin of cancer
    Païvi Peltomäki · 2011 · Experimental Cell Research
34. Causes and consequences of microsatellite instability in gastric carcinogenesis
    Sérgia Velho · 2014 · World Journal of Gastroenterology
35. Screening for Germline Mismatch Repair Mutations Following Diagnosis of Sebaceous Neoplasm
    Jessica N. Everett, Victoria M. Raymond, Monica Dandapani, Monica L. Marvin, Wendy K. Kohlmann, Anu B. Chittenden, Erika S. Koeppe, Shanna L. Gustafson, Tobias Else, Douglas Randall Fullen et al. · 2014 · JAMA Dermatology
36. The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of colorectal cancer, 2024 update
    Feng Wang, Gong Chen, Zhen Zhang, Ying Yuan, Yi Wang, Yuanhong Gao, Weiqi Sheng, Zixian Wang, Xinxiang Li, Xianglin Yuan et al. · 2024 · 癌症：英文版
37. The genetic basis of colorectal cancer in a population-based incident cohort with a high rate of familial disease
    Michael O. Woods, H. Banfield Younghusband, Patrick S. Parfrey, Steve Gallinger, John R McLaughlin, Elizabeth L. Dicks, Susan N. Stuckless, Aaron F. Pollett, Bharati V. Bapat, Miralem Mrkonjic et al. · 2010 · Gut
38. Gynecological Cancers Caused by Deficient Mismatch Repair and Microsatellite Instability
    Madhura Deshpande, Phillip A. Romanski, Zev Rosenwaks, Jeannine Gerhardt · 2020 · Cancers
39. Identification of candidate predisposing copy number variants in familial and early‐onset colorectal cancer patients
    Ramprasath Venkatachalam, Eugène T.P. Verwiel, Eveline J. Kamping, Eveline Hoenselaar, Heike Görgens, Hans K. Schackert, J. Han van Krieken, Marjolijn J. L. Ligtenberg, Nicoline Hoogerbrugge, Ad Geurts van Kessel et al. · 2010 · International Journal of Cancer
40. The clinical utility of microsatellite instability in colorectal cancer
    Zhenli Diao, Yanxi Han, Yuqing Chen, Rui Zhang, Jinming Li · 2020 · Critical Reviews in Oncology/Hematology
41. Detection of MGMT Promoter Methylation in Normal Individuals Is Strongly Associated with the T Allele of the rs16906252 MGMT Promoter Single Nucleotide Polymorphism
    Ida L. M. Candiloro, Alexander Dobrovic · 2009 · Cancer Prevention Research
42. Recent insights into the pathogenesis of colorectal cancer
    Ajay Goel, Clement Richard Boland · 2009 · Current Opinion in Gastroenterology
43. Epigenetic Repression of DNA Mismatch Repair by Inflammation and Hypoxia in Inflammatory Bowel Disease–Associated Colorectal Cancer
    Robert A. Edwards, Mavee Witherspoon, Kehui Wang, Kambiz Afrasiabi, Trang Thuy Pham, Lutz Birnbaumer, Steven M. Lipkin · 2009 · Cancer Research
44. Germline Copy Number Variations and Cancer Predisposition
    Ana Cristina Victorino Krepischi, Peter Lees Pearson, Carla Rosenberg · 2012 · Future Oncology
45. Hereditary cancer syndromes
    Евгений Наумович Имянитов, Ekatherina Sh. Kuligina, Анна Петровна Соколенко, Evgeny N. Suspitsin, Grigoriy A. Yanus, Aglaya G. Iyevleva, Alexandr O. Ivantsov, Светлана Николаевна Алексахина · 2023 · World Journal of Clinical Oncology
46. The fate is not always written in the genes: Epigenomics in epidemiologic studies
    Scott M. Langevin, Karl T. Kelsey · 2013 · Environmental and Molecular Mutagenesis
47. Results and challenges of immune checkpoint inhibitors in colorectal cancer
    Sheik Emambux, Gaëlle Tachon, Audelaure Junca, David Tougeron · 2018 · Expert Opinion on Biological Therapy
48. A review on the molecular diagnostics of Lynch syndrome: a central role for the pathology laboratory
    Margot G. van Lier, Anja Wagner, Monique Esther van Leerdam, Katharina Biermann, Ernst Johan Kuipers, Ewout Willem Steyerberg, Hendrikus Jan Dubbink, Winand N.M. Dinjens · 2009 · Journal of Cellular and Molecular Medicine
49. Macro lncRNAs
    Philipp M. Guenzl, Denise P. Barlow · 2012 · RNA Biology
50. Yield of routine molecular analyses in colorectal cancer patients ≤70 years to detect underlying Lynch syndrome
    Margot G. van Lier, Celine H. Leenen, Anja Wagner, Dewkoemar Ramsoekh, Hendrikus Jan Dubbink, Ans MW van den Ouweland, Pieter J. Westenend, Eelco J. R. de Graaf, Leonieke M. M. Wolters, Wietske W Vrijland et al. · 2011 · The Journal of Pathology
51. Update on Hereditary Colorectal Cancer: Improving the Clinical Utility of Multigene Panel Testing
    Marie Lorans, Eryn Dow, Finlay Macrae, Ingrid Winship, Daniel D. Buchanan · 2018 · Clinical Colorectal Cancer
52. Prevalence of Alterations in DNA Mismatch Repair Genes in Patients With Young-Onset Colorectal Cancer
    Paul J. Limburg, William Scott Harmsen, Helen Chen, Steve Gallinger, Robert W. Haile, John A. Baron, Graham Casey, Michael O. Woods, Stephen N. Thibodeau, Noralane M. Lindor · 2010 · Clinical Gastroenterology and Hepatology
53. Clinical significance of microsatellite instability in colorectal cancer
    Matthias Kloor, Laura Staffa, Aysel Ahadova, Magnus von Knebel Doeberitz · 2013 · Langenbeck s Archives of Surgery
54. Genetics and Genetic Testing in Hereditary Colorectal Cancer
    Elena M. Stoffel, Clement Richard Boland · 2015 · Gastroenterology
55. Epimutations and cancer predisposition: importance and mechanisms
    Luke B. Hesson, Megan Philippa Hitchins, Robyn Lynne Ward · 2010 · Current Opinion in Genetics & Development
56. Genetic Counseling Considerations in the Evaluation of Families for Lynch Syndrome—A Review
    Scott M. Weissman, Cecelia A. Bellcross, Christina Chimera Bittner, Mary E. Freivogel, Joy Larsen Haidle, Pardeep Kaurah, Anna Leininger, Selvi Palaniappan, Kelle J. Steenblock, Thuy M. Vu et al. · 2010 · Journal of Genetic Counseling
57. Chemoresistance of colorectal cancer to 5-fluorouracil is associated with silencing of the BNIP3 gene through aberrant methylation
    Jianming He, Li Pei, Heng Jiang, Weiwen Yang, Jianfang Chen, Houjie Liang · 2017 · Journal of Cancer
58. Racial differences in endometrial cancer molecular portraits in The Cancer Genome Atlas
    David S. Guttery, Kevin Blighe, Konstantinos Polymeros, Raymond P. Symonds, Salvador Macip, Esther Louise Moss · 2018 · Oncotarget
59. Evidence of constitutional MLH1 epimutation associated to transgenerational inheritance of cancer susceptibility
    Michel Crépin, Marie‐Claire Dieu, Sophie Lejeune, Fabienne Escande, Denis Boidin, Nicole Porchet, Gilles Morin, Sylvie Manouvrier‐Hanu, Michèle Mathieu, Marie‐Pierre Buisine · 2011 · Human Mutation
60. Screening and surveillance in hereditary gastrointestinal cancers: Recommendations from the European Society of Digestive Oncology (ESDO) expert discussion at the 20th European Society for Medical Oncology (ESMO)/World Congress on Gastrointestinal Cancer, Barcelona, June 2018
    Deepak Vangala, Estelle Cauchin, Judith Balmañà, Lucjan Stanislaw Wyrwicz, Eric Van Cutsem, Ulrich Güller, Antoni Castells, Fátima Carneiro, Pascal R. Hammel, Michel Pierre Ducreux et al. · 2018 · European Journal of Cancer
61. A cryptic paracentric inversion ofMSH2exons 2–6 causes Lynch syndrome
    Qing Liu, Luke B. Hesson, Andrea C. Nunez, Deborah Packham, Rachel Williams, Robyn Lynne Ward, Mathew A. Sloane · 2015 · Carcinogenesis
62. Update on Hereditary Colorectal Cancer
    Felipe Cavalcanti Carneiro da Silva, Patrik Wernhoff, Constantino Dominguez‐Barrera, Mev Dominguez–Valentin · 2016 · Anticancer Research
63. The missing heritability of familial colorectal cancer
    Stephanie A Schubert, Hans M. Morreau, Noel F.C.C. de Miranda, Tom van Wezel · 2019 · Mutagenesis
64. Multigenerational epigenetic inheritance: One step forward, two generations back
    Tuscher, Jennifer J., Day, Jeremy J. · 2019 · Neurobiology of Disease
65. A Survey of Rare Epigenetic Variation in 23,116 Human Genomes Identifies Disease-Relevant Epivariations and CGG Expansions
    Paras Garg, Bharati Jadhav, Oscar L. Rodriguez, Nihir Patel, Alejandro Martin-Trujillo, Miten Jain, Sofie Metsu, Hugh E. Olsen, Benedict Paten, Beate R. Ritz et al. · 2020 · The American Journal of Human Genetics
66. The molecular basis of EPCAM expression loss in Lynch syndrome-associated tumors
    Cathrin Huth, Matthias Kloor, Anita Yvonne Voigt, Gergana Bozukova, Christina Evers, Harald Gaspar, Mirjam Tariverdian, Peter Schirmacher, Magnus von Knebel Doeberitz, Hendrik Bläker · 2012 · Modern Pathology
67. Lynch Syndrome-Associated Extracolonic Tumors Are Rare in Two Extended Families With the Same EPCAM Deletion
    Henry T. Lynch, Douglas L. Riegert‐Johnson, Carrie Snyder, Jane F. Lynch, Jill M. Hagenkord, Clement Richard Boland, Jennifer Rhees, Stephen N. Thibodeau, Lisa A Boardman, Janine Marie Davies et al. · 2011 · The American Journal of Gastroenterology
68. Clinical Aspects of Microsatellite Instability Testing in Colorectal Cancer
    Mehrdad Zeinalian, Morteza Hashemzadeh Chaleshtori, Rasoul Salehi, Mohammad Hassan Emami · 2018 · Advanced Biomedical Research
69. Epigenetic Drivers of Genetic Alterations
    Minoru Toyota, Hiromu Suzuki · 2010 · Advances in genetics
70. Screening for Lynch Syndrome in Colorectal Cancer: Are We Doing Enough?
    Guillaume Canard, Jérémie H. Lefèvre, Chrystelle Colas, Florence Coulet, Magali Svrcek, Olivier Lascols, Richard Hamelin, Conor J. Shields, Alex Duval, Jean–François Fléjou et al. · 2011 · Annals of Surgical Oncology
71. Mismatch repair genes founder mutations and cancer susceptibility in Lynch syndrome
    Giovanni Ponti, Ester Castellsagué, Cristel Ruini, Antonio Percesepe, Aldo Tomasi · 2014 · Clinical Genetics
72. Review: Clinical aspects of hereditary DNA Mismatch repair gene mutations
    Rolf H. Sijmons, Robert M.W. Hofstra · 2015 · DNA repair
73. Role of Deficient Mismatch Repair in the Personalized Management of Colorectal Cancer
    Congmin Zhang, Jinfeng Lv, Liang Gong, Linyu Yu, Xiaoping Chen, Hong‐Hao Zhou, Lan Fan · 2016 · International Journal of Environmental Research and Public Health
74. Molecular characterization of endometrial cancer and therapeutic implications
    Boris J. N. Winterhoff, Lauren Thomaier, Sally A. Mullany, Matthew A. Powell · 2019 · Current Opinion in Obstetrics & Gynecology
75. Endometrial cancer gene panels: clinical diagnostic vs research germline DNA testing
    Amanda B. Spurdle, Michael A Bowman, Jannah Shamsani, Judy Kirk · 2017 · Modern Pathology
76. Pancreatic cancer in Lynch syndrome patients
    Bujanda, Luis, Herreros-Villanueva, Marta · 2017 · Journal of Cancer
77. Molecular characterization of endometrial cancer and therapeutic implications
    Zenas Chang, Shobhana Talukdar, Sally A. Mullany, Boris J. N. Winterhoff · 2018 · Current Opinion in Obstetrics & Gynecology
78. Epigenetic Deregulation of DNA Repair and Its Potential for Therapy
    Monika E. Hegi, Davide Sciuscio, Anastasia Murat, Marc Levivier, Roger Stupp · 2009 · Clinical Cancer Research
79. Shedding light on the EpCAM: An overview
    Seyed Muhammad Yahyazadeh Mashhadi, Monireh Kazemimanesh, Arash Arashkia, Kayhan Azadmanesh, Zahra Meshkat, Behrouz Golichenari, Amirhosein Sahebkar · 2019 · Journal of Cellular Physiology
80. Hereditary and Common Familial Colorectal Cancer: Evidence for Colorectal Screening
    Niloy Jewel Samadder, Kory W. Jasperson, Randall W. Burt · 2014 · Digestive Diseases and Sciences
81. De novo DNA methyltransferase activity in colorectal cancer is directed towards H3K36me3 marked CpG islands
    Roza H. Ali Masalmeh, Francesca Taglini, Cristina Rubio-Ramon, Kamila Irena Musialik, Jonathan Higham, Hazel Davidson‐Smith, Ioannis Kafetzopoulos, Kamila P. Pawlicka, Hannah Finan, Richard C. Clark et al. · 2021 · Nature Communications
82. Inheritance of Epigenetic Aberrations (Constitutional Epimutations) in Cancer Susceptibility
    Megan Philippa Hitchins · 2010 · Advances in genetics
83. How Should We Test for Lynch Syndrome? A Review of Current Guidelines and Future Strategies
    Richard Gallon, Peter Gawthorpe, Rachel Phelps, Christine M. Hayes, Gillian M. Borthwick, Mauro Santibanez‐Koref, Michael S. Jackson, John Burn · 2021 · Cancers
84. Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition?
    Eddy H.J. Van Roon, Marjo van Puijenbroek, Anneke Middeldorp, Ronald van Eijk, Emile J. de Meijer, Dianhdra D. Erasmus, Kim AD Wouters, Manon van Engeland, Jan Oosting, Frederik Jan Hes et al. · 2010 · BMC Cancer
85. High-level Microsatellite Instability in Appendiceal Carcinomas
    Melissa W. Taggart, John M. Galbincea, Paul F. Mansfield, Keith F. Fournier, Richard Eldon Royal, Michael James Overman, Asif Rashid, Susan C. Abraham · 2013 · The American Journal of Surgical Pathology
86. The diversity of tumours with microsatellite instability: molecular mechanisms and impact upon microsatellite instability testing and mismatch repair protein immunohistochemistry
    Jinru Shia · 2020 · Histopathology
87. Microsatellite Instability: From the Implementation of the Detection to a Prognostic and Predictive Role in Cancers
    Martina Amato, Renato Franco, Gaetano Facchini, Raffaele Addeo, Fortunato Ciardiello, Massimiliano Berretta, Giulia Vita, Alessandro Sgambato, Sandro Pignata, Michele Caraglia et al. · 2022 · International Journal of Molecular Sciences
88. Predictive Biomarkers and Resistance Mechanisms of Checkpoint Inhibitors in Malignant Solid Tumors
    Luciana Alexandra Pavelescu, Robert Mihai Enache, Oana Alexandra Roşu, Monica Profir, Sanda Maria Creţoiu, Bogdan Severus Gașpar · 2024 · International Journal of Molecular Sciences
89. MLH1 methylation screening is effective in identifying epimutation carriers
    Marta Pineda, Pilar Mur, Maria D. Iniesta, Ester Borràs, Olga Campos, Gardenia Vargas‐Parra, Silvia L. Iglesias, Anna Fernández, Stephen B. Gruber, Conxi Lázaro et al. · 2012 · European Journal of Human Genetics
90. Methylome profiling of healthy and central precocious puberty girls
    Danielle de Souza Bessa, Mariana Camargo Maschietto, Carlos Francisco Aylwin, Ana Pinheiro Machado Canton, Vinícius Nahime Brito, Delanie Bulcão Macedo, Marina Cunha-Silva, Heloísa Marcelina da Cunha Palhares, Elisabete A. M. R. de Resende, Maria de Fátima Borges et al. · 2018 · Clinical Epigenetics
91. Immunotherapy of MSI Cancer: Facts and Hopes
    Helen Catherine Wilbur, Dung Thi Le, Parul Agarwal · 2023 · Clinical Cancer Research
92. Epimutation and cancer: A new carcinogenic mechanism of Lynch syndrome
    Kouji Banno, Iori Kisu, Megumi Yanokura, Kosuke Tsuji, Kenta Masuda, Arisa Ueki, Yusuke Kobayashi, Wataru Yamagami, Hiroyuki Nomura, Eiichiro Tominaga et al. · 2012 · International Journal of Oncology
93. Hereditary Colorectal Cancer
    Lodewijk A.A. Brosens, G. Johan A. Offerhaus, Francis M. Giardiello · 2015 · Surgical Clinics of North America
94. Mutation deep within an intron of MSH2 causes Lynch syndrome
    Mark Clendenning, Daniel D. Buchanan, Michael D. Walsh, Belinda Nagler, Christophe Rosty, Bryony A. Thompson, Amanda B. Spurdle, John Llewelyn Hopper, Mark A. Jenkins, Joanne P Young · 2011 · Familial Cancer
95. Epigenetic mechanisms in the pathogenesis of Lynch syndrome
    Païvi Peltomäki · 2014 · Clinical Genetics
96. Monozygotic twins discordant for constitutiveBRCA1promoter methylation, childhood cancer and secondary cancer
    Danuta Galetzka, Tamara Hansmann, Nady El Hajj, Eva Weis, Benjamin Irmscher, Marco Ludwig, Brigitte Schneider-Rätzke, Nicolai Kohlschmidt, Vera Beyer, Oliver Bartsch et al. · 2012 · Epigenetics
97. White Blood Cell BRCA1 Promoter Methylation Status and Ovarian Cancer Risk
    Per Eystein Lønning, Elisabet Ognedal Berge, Merete Bjørnslett, Laura Minsaas, Ranjan Chrisanthar, Hildegunn Høberg‐Vetti, Cécile Dulary, Florence Busato, Silje Bjørneklett, Christine Eriksen et al. · 2018 · Annals of Internal Medicine
98. Contribution of MLH 1 constitutional methylation for Lynch syndrome diagnosis in patients with tumor MLH 1 downregulation
    Diana Pinto, Carla Pinto, Joana Guerra, Manuela Pinheiro, Rui Pedro Santos, Hege Marie Vedeld, Zeremariam Yohannes, Ana Peixoto, Catarina Santos, Pedro Pinto et al. · 2018 · Cancer Medicine
99. Cancer risks in Lynch syndrome, Lynch-like syndrome, and familial colorectal cancer type X: a prospective cohort study
    Karolin Bucksch, Silke Zachariae, Stefan Aretz, Reinhard Büttner, Elke Holinski‐Feder, Stefanie Holzapfel, Robert Hüneburg, Matthias Kloor, Magnus von Knebel Doeberitz, Monika Morak et al. · 2020 · BMC Cancer
100. Genetic and Epigenetic Traits as Biomarkers in Colorectal Cancer
     Marianne Berg, Kjetil Søreide · 2011 · International Journal of Molecular Sciences